Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania DALLAS and HOBART, Australia, July 1, 2026 /PRNewswire/ -- The Colossal Foundation, the nonprofit conservation arm of Colossal Biosciences, today announced a new partnership with the University of Tasmania to support efforts to combat Devil facial tumour disease (DFTD), a fatal transmiss